At the time of writing, GSK Plc ADR [GSK] stock is trading at $35.37, down -0.87%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GSK shares have gain 2.58% over the last week, with a monthly amount drifted -12.43%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GSK Plc ADR [NYSE: GSK] stock has seen the most recent analyst activity on April 15, 2025, when Exane BNP Paribas initiated its Neutral rating and assigned the stock a price target of $35.25. On November 15, 2024, downgrade downgraded it’s rating to Hold. Jefferies downgraded its rating to a Hold and decreased its price target to $39.50 on November 12, 2024. Guggenheim downgraded its rating to a Neutral. UBS downgraded its rating to Neutral for this stock on July 08, 2024. In a note dated May 30, 2024, Goldman initiated an Neutral rating and provided a target price of $47 on this stock.
For the past year, the stock price of GSK Plc ADR fluctuated between $31.72 and $45.92. Currently, Wall Street analysts expect the stock to reach $58 within the next 12 months. GSK Plc ADR [NYSE: GSK] shares were valued at $35.37 at the most recent close of the market. An investor can expect a potential return of 63.98% based on the average GSK price forecast.
Analyzing the GSK fundamentals
According to GSK Plc ADR [NYSE:GSK], the company’s sales were 40.10B for trailing twelve months, which represents an 4.14% jump. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.18 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.14 points at the first support level, and at 34.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.75, and for the 2nd resistance point, it is at 36.12.
Ratios To Look Out For
It is important to note that GSK Plc ADR [NYSE:GSK] has a current ratio of 0.78. As well, the Quick Ratio is 0.52, while the Cash Ratio is 0.17. Considering the valuation of this stock, the price to sales ratio is 1.79, the price to book ratio is 4.22 and price to earnings (TTM) ratio is 22.35.
Transactions by insiders
Recent insider trading involved GSK plc, 10% Owner, that happened on Sep 27 ’24 when 2.79 million shares were purchased.
